Cell junctional proteins in the human corpus luteum: Changes during the normal cycle and after HCG treatment

Human Reproduction

Volumn 21, Issue 12, 2006, Pages 3096-3102

  Groten, T ^a   Fraser, H M ^b   Duncan, W C ^c   Konrad, R ^a   Kreienberg, R ^a   Wulff, Christine ^a  

^a UNIVERSITY OF ULM   (Germany)

^b MRC Reproductive Biology Unit   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Adherens junctions; Corpus luteum; Junction proteins; Permeability; Tight junctions

Indexed keywords

3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; CD34 ANTIGEN; CHORIONIC GONADOTROPIN; CLAUDIN; CLAUDIN 1; CLAUDIN 5; OCCLUDIN; STEROID 17ALPHA MONOOXYGENASE; VASCULAR ENDOTHELIAL CADHERIN;

ARTICLE; CELL JUNCTION; CELL MEMBRANE; CONTROLLED STUDY; CORPUS LUTEUM FUNCTION; DOWN REGULATION; ENDOTHELIUM CELL; FEMALE; FIRST TRIMESTER PREGNANCY; GRANULOSA CELL; HORMONAL REGULATION; HUMAN; HUMAN TISSUE; HYSTERECTOMY; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LUTEAL CELL; LUTEAL PHASE; MENSTRUAL CYCLE; OVARY FUNCTION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; THECA CELL; TIGHT JUNCTION; TISSUE FIXATION; TISSUE SECTION;

EID: 33751362820     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/del286     Document Type: Article

References (40)

1. Albert C, Garrido N, Mercader A, Rao CV, Remohi J, Simon C and Pellicer A (2002) The role of endothelial cells in the pathogenesis of ovarian hyperstimulation syndrome. Mol Hum Reprod 8,409-418.
2. Bazzoni G and Dejana E (2004) Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol Rev 84,869-901.
3. Budev MM, Arroliga AC and Falcone T (2005) Ovarian hyperstimulation syndrome. Crit Care Med 33,S301-S306.
4. Dejana E (2004) Endothelial cell-cell junctions: Happy together. Nat Rev Mol Cell Biol 5,261-270.
5. Dejana E, Lampugnani MG, Martinez-Estrada O and Bazzoni G (2000) The molecular organization of endothelial junctions and their functional role in vascular morphogenesis and permeability. Int J Dev Biol 44,743-748.
6. Duncan WC, McNeilly AS, Fraser HM and Illingworth PJ (1996) Luteinizing hormone receptor in the human corpus luteum: Lack of down-regulation during maternal recognition of pregnancy. Hum Reprod 11,2291-2297.
7. Dvorak HF (2002) Vascular permeability factor/vascular endothelial growth factor: A critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J Clin Oncol 20,4368-4380.
8. Fraser HM and Duncan WC (2005) Vascular morphogenesis in the primate ovary. Angiogenesis 8,101-116.
9. Fraser HM, Bell J, Wilson H, Taylor PD, Morgan K, Anderson RA and Duncan WC (2005a) Localization and quantification of cyclic changes in the expression of endocrine gland vascular endothelial growth factor in the human corpus luteum. J Clin Endocrinol Metab 90,427-434.
10. Fraser HM, Wilson H, Morris KD, Swanston I and Wiegand SJ (2005b) Vascular endothelial growth factor Trap suppresses ovarian function at all stages of the luteal phase in the macaque. J Clin Endocrinol Metab 90,5811-5818.
11. Fujibe M, Chiba H, Kojima T, Soma T, Wada T, Yamashita T and Sawada N (2004) Thr203 of claudin-1, a putative phosphorylation site for MAP kinase, is required to promote the barrier function of tight junctions. Exp Cell Res 295,36-47.
12. Gonzalez-Mariscal L, Betanzos A, Nava P and Jaramillo BE (2003) Tight junction proteins. Prog Biophys Mol Biol 81,1-44.
13. Harhaj NS and Antonetti DA (2004) Regulation of tight junctions and loss of barrier function in pathophysiology. Int J Biochem Cell Biol 36,1206-1237.
14. Illingworth PJ, Reddi K, Smith K and Baird DT (1990) Pharmacologic 'rescue' of the corpus luteum results in increased inhibin production. Clin Endocrinol 33,323-332.
15. Khan-Dawood FS, Yang J and Dawood MY (1996a) Immunocytochemical localization and expression of E-cadherin and beta-catenin in the human corpus luteum. Mol Hum Reprod 2,753-757.
16. Khan-Dawood FS, Yang J and Dawood MY (1996b) Localization and expression of zonula occludens-1 tight junction-associated protein in baboon (Papio anubis) corpora lutea. Hum Reprod 11,1262-1267.
17. Kitajima Y, Endo T, Nagasawa K, Manase K, Honnma H, Baba T, Hayashi T, Chiba H, Sawada N and Saito T (2006) Hyperstimulation and a gonadotropin-releasing hormone agonist modulate ovarian vascular permeability by altering expression of the tight junction protein claudin-5. Endocrinology 147,694-699.
18. Langbein L, Grund C, Kuhn C, Praetzel S, Kartenbeck J, Brandner JM, Moll I and Franke WW (2002) Tight junctions and compositionally related junctional structures in mammalian stratified epithelia and cell cultures derived therefrom. Eur J Cell Biol 81,419-435.
19. Leach L, Babawale MO, Anderson M and Lammiman M (2002) Vasculogenesis, angiogenesis and the molecular organisation of endothelial junctions in the early human placenta. J Vasc Res 39,246-259.
20. Lei ZM, Reshef E and Rao CV (1992) The expression of human chorionic gonadotropin/luteinizing hormone receptors in human endometrial and myometrial blood vessels. J Clin Endocrinol Metab 75(2),651-659.
21. Levin ER, Rosen GF, Cassidenti DL, Yee B, Meldrum D, Wisot A and Pedram A (1998) Role of vascular endothelial cell growth factor in ovarian hyperstimulation syndrome. J Clin Invest 102,1978-1985.
22. Matter K and Balda MS (2003) Functional analysis of tight junctions. Methods 30,228-234.
23. Misrahi M, Beau I, Ghinea N, Vannier B, Loosfelt H, Meduri G, Vu Hai MT and Milgrom E (1996) The LH/CG and FSH receptors: Different molecular forms and intracellular traffic. Mol Cell Endocrinol 125,161-167.
24. Morita K, Sasaki H, Furuse M and Tsukita S (1999) Endothelial claudin: claudin-5/TMVCF constitutes tight junction strands in endothelial cells. J Cell Biol 147,185-194.
25. Morita K, Sasaki H, Furuse K, Furuse M, Tsukita S and Miyachi Y (2003) Expression of claudin-5 in dermal vascular endothelia. Exp Dermatol 12,289-295.
26. Orvieto R (2005) Can we eliminate severe ovarian hyperstimulation syndrome? Hum Reprod 20,320-322.
27. Pellicer A, Albert C, Mercader A, Bonilla-Musoles F, Remohi J and Simon C (1999) The pathogenesis of ovarian hyperstimulation syndrome: In vivo studies investigating the role of interleukin-1beta, interleukin-6, and vascular endothelial growth factor. Fertil Steril 71,482-489.
28. Peppi M and Ghabriel MN (2004) Tissue-specific expression of the tight junction proteins claudins and occludin in the rat salivary glands. J Anat 205,257-266.
29. Rao CV, Li X, Toth P, Lei ZM and Cook VD (1993) Novel expression of functional human chorionic gonadotropin/luteinizing hormone receptor gene in human umbilical cords. J Clin Endocrinol Metab 77,1706-1714.
30. Rodger FE, Young FM, Fraser HM and Illingworth PJ (1997) Endothelial cell proliferation follows the mid-cycle luteinizing hormone surge, but not human chorionic gonadotrophin rescue, in the human corpus luteum. Hum Reprod 12,1723-1729.
31. Schneeberger EE and Lynch RD (2004) The tight junction: A multifunctional complex. Am J Physiol Cell Physiol 286,C1213-C1228.
32. Sundfeldt K, Piontkewitz Y, Billig H and Hedin L (2000) E-cadherin-catenin complex in the rat ovary: Cell-specific expression during folliculogenesis and luteal formation. J Reprod Fertil 118,375-385.
33. Vestweber D (2000) Molecular mechanisms that control endothelial cell contacts. J Pathol 190,281-291.
34. Virgintino D, Errede M, Robertson D, Capobianco C, Girolamo F, Vimercati A, Bertossi M and Roncali L (2004) Immunolocalization of tight junction proteins in the adult and developing human brain. Histochem Cell Biol 122,51-59.
35. Vorbrodt AW and Dobrogowska DH (2004) Molecular anatomy of interendothelial junctions in human blood-brain barrier microvessels. Folia Histochem Cytobiol 42,67-75.
36. Walz A, Keck C, Weber H, Kissel C and Pietrowski D (2005) Effects of luteinizing hormone and human chorionic gonadotropin on corpus luteum cells in a spheroid cell culture system. Mol Reprod Dev 72,98-104.
37. Wulff C, Wilson H, Largue P, Duncan WC, Armstrong DG and Fraser HM (2000) Angiogenesis in the human corpus luteum: Localization and changes in angiopoietins, Tie-2 and vascular endothelial growth factor messenger ribonucleic acid. J Clin Endocrinol Metab 85,4302-4309.
38. Wulff C, Dickson SE, Duncan WC and Fraser HM (2001a) Angiogenesis in the human corpus luteum: Simulating early pregnancy by hCG treatment is associated with both angiogenesis and vessel stabilisation. Hum Reprod 16,2515-2524.
39. Wulff C, Wilson H, Rudge JS, Wiegand SJ, Lunn SF and Fraser HM (2001b) Luteal angiogenesis: Prevention or intervention by treatment with vascular endothelial growth factor TrapA40. J Clin Endocrinol Metab 86,3377-3386.
40. Zhu Y, Maric J, Nilsson M, Brannstrom M, Janson PO and Sundfeldt K (2004) Formation and barrier function of tight junctions in human ovarian surface epithelium. Biol Reprod 71,53-59.